222 results
8-K
EX-1.1
djr4flhlhsk7uebk2xe
26 Feb 24
Other Events
5:08pm
424B5
5252dic2pa22
26 Feb 24
Prospectus supplement for primary offering
6:12am
424B5
q66g4nl
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
gigcx0s4wx0rn zbt8k0
12 Feb 24
AbbVie Completes Acquisition of ImmunoGen
7:49am
8-K
EX-99.1
elh4u0jm48q c1
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
11-K
x1rtt5f8a3ao
28 Jun 23
Annual report of employee stock purchases
5:00pm